Designs for Single- or Multiple-Agent Phase I Trials-Reference-Cited by-同舟云学术

Designs for Single- or Multiple-Agent Phase I Trials

Published:2004-08-27 Issue:3 Volume:60 Page:661-669
ISSN:0006-341X
Container-title:Biometrics
language:en
Short-container-title:

Author:

Conaway Mark R.,Dunbar Stephanie,Peddada Shyamal D.

Publisher

Wiley

Subject

Applied Mathematics,General Agricultural and Biological Sciences,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,Statistics and Probability

Reference22 articles.

1. An evaluation of phase I clinical trials;Ahn;Statistics in Medicine,1998

2. Cancer phase I clinical trials: Efficient dose escalation with overdose control;Babb;Statistics in Medicine,1998

3. On improved estimation of parameters subject to order restrictions;Dunbar;Statistics and Applications,2001

4. A random walk rule for phase I clinical trials;Durham;Biometrics,1997

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual‐agent dose‐finding in Phase I clinical trial—An extension of rapid enrollment design;Statistics in Medicine;2024-07-29

2. Applications of the partial-order continual reassessment method in the early development of treatment combinations;Clinical Trials;2024-03-30

3. Isotonic Phase I Cancer Clinical Trial Design Utilizing Patient-Reported Outcomes;Statistics in Biopharmaceutical Research;2023-11-28

4. Data-dependent early completion of dose-finding trials for drug-combination;Statistical Methods in Medical Research;2023-02-12

5. Isotonic design for phase I cancer clinical trials with late-onset toxicities;Journal of Biopharmaceutical Statistics;2023-01-06